In 1993 Dr. Maksoud established Maksoud Pharm Inc., a chain of independent retail pharmacies in the tri-state area. Later, he launched Community Care Rx, Inc., a long-term care pharmacy opening for business in September 2010 to focus on serving the long-term care facilities in the 5 boroughs, Long Island and Westchester. In 2013 Community Care Rx celebrated the opening of A New Jersey location in the town of Totowa.

 
After Mr. Maksoud’s success with Community Care Rx, he opened Community Care Consulting which provides clinical expertise and services to a wide variety of healthcare settings by experienced consultant pharmacists. He is also the founder of Community Care Specialty Pharmacy which works with the entire health care ecosystem to connect patients who have chronic and rare conditions to medication, information and funding. ​

Mathew Cherian is currently retired from his position as Director and Senior Fellow at a Leading Pharmaceutical Company. He is a 34-year industry veteran with a significant track record in the pharmaceutical industry (US and Europe). Mathew oversaw leading early-stage development of products and coordinated his work between multiple worldwide sites of Pfizer. His expertise and experience in complex products is helping drive development of products in multiple therapeutic areas.

Mathew is an expert in drug/device combination products and leads efforts to develop Differentiated Drug Delivery systems, which are highly coveted value-added products. 
Mathew holds a Ph.D. in chemical engineering from the University of Rhode Island, is an inventor and has several patents. He is recognized in the industry as a thought- leader, and regularly makes presentations on current topics. Mathew serves on the Executive Committee of International Pharmaceutical Society. 

​

Email

Dr. Thomas Ingallinera is advisor to Dawah Pharmaceuticals. He provides technical support in pharmaceutics. Dr. Tom has over 40 years of experience in pharmaceutical development, with particular expertise in parenteral dosage forms. He has advised on product development programs across the continuum, from pre-formulation through commercial production. He has worked at several leading pharmaceutical companies including Pharmaceutics International, BioCryst Pharmaceuticals, Parenta Pharmaceuticals, AAI Pharma, Genzyme, Burroughs Wellcome, and A.H. Robins. Dr. Ingallinera has a B.S. in Pharmacy with a Ph.D. in Pharmaceutics from Virginia Commonwealth University. Dr. Tom also serves as a member of the Technical Advisory Group for the Bill and Melinda Gates Foundation.

Nicholas Vartanian comes from a diverse background. Nicholas worked under the direction of the previous Mayor of Los Angeles, Antonio Villaraigosa, as an International Trade Analyst. During his tenure in the Mayor's office, Nicholas worked with Austin Beutner to acquire foreign direct investment dealing with investors such as Sheikh Mohammed bin Rashid al-Maktum of Dubai, previous Prime Minister of England Tony Blair, SVP of Forever 21 Christopher Lee, and assisted in securing a BYD electric car manufacturing plant in Los Angeles. 

After leaving the public arena Nicholas joined The Luskin Center for Innovation, an economic think tank, where he co-authored a policy for a Feed-in-Tariff (FiT) taxation system for solar power on commercial rooftop properties. This was unanimously adopted by the City of Los Angeles and the Department of Water and Power. For the last 8 years, Nicholas has been working in the healthcare industry discovering effective ways to make changes within the industry holding executive positions within the pharmaceutical and clinical laboratory space.

​

Email

(placeholder)

Amany El Megharbel brings over 29 years of experience in finance and banking, specializing in private banking, asset management, and digital banking solutions. She served as Head of Branches, Financial Institutions, and Asset Management at Banque Misr UAE, significantly enhancing operational efficiencies and profitability. Earlier, she successfully launched BLOM Bank Egypt's Private Banking division and led innovative banking projects at Credit Agricole and Egyptian American Bank.

​

Amany holds certifications in Wealth Management and Financial Planning & Asset Allocation, alongside a BA in Commercial Sciences, reinforcing her strategic role at Dawah Pharma.

Edward Finney is an experienced commercial executive with a command of strategic planning and tactical execution, resulting in maximized financial performance.  He has held numerous senior organizational positions and has successfully launched numerous brands with pharmaceutical and medical services companies in multiple therapeutic areas and markets.  Mr. Finney has been successful through a disciplined business approach which includes, but is not limited to, strong strategic planning, resolute financial oversight, an inspirational leadership style, putting in place key metrics to evaluate performance, and an unbridled focus on the customer, results, and profitability. 

He is known as an innovative, visionary and collaborative leader who develops his senior managers and is an expert at launching new products and building commercial functions. Mr. Finney has successfully led organizations through 8 strategic transactions.  He holds an MA in Management from Webster University and an MBA from the University of California, Irvine.  Prior to his healthcare career, Ed was an Officer in the United States Army. ​